Automate Your Wheel Strategy on PGNY
With Tiblio's Option Bot, you can configure your own wheel strategy including PGNY - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PGNY
- Rev/Share 14.4808
- Book/Share 6.0049
- PB 4.2082
- Debt/Equity 0.0495
- CurrentRatio 2.6966
- ROIC 0.0841
- MktCap 2178568497.0
- FreeCF/Share 2.2176
- PFCF 11.4543
- PE 40.7973
- Debt/Assets 0.0335
- DivYield 0
- ROE 0.1155
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 3
- P/B Score 2
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | PGNY | KeyBanc Capital Markets | Sector Weight | Overweight | -- | $30 | Nov. 12, 2025 |
| Upgrade | PGNY | Leerink Partners | Market Perform | Outperform | -- | $28 | July 8, 2025 |
| Downgrade | PGNY | JMP Securities | Mkt Outperform | Market Perform | -- | -- | Sept. 19, 2024 |
News
Is Progyny (PGNY) a Solid Growth Stock? 3 Reasons to Think "Yes"
Published: November 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Progyny (PGNY) possesses solid growth attributes, which could help it handily outperform the market.
Read More
New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action
Published: November 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in family building solutions, today announced new men's health research exploring experiences and views on fertility. The findings shed light on how men in the U.S. view their role in the fertility journey and the barriers that prevent many from getting the care they need for successful conception.
Read More
Does Progyny Stock Lead The Pack?
Published: November 18, 2025 by: Forbes
Sentiment: Positive
Progyny is a leader in fertility benefits, offering employers comprehensive, outcomes-based solutions that improve treatment success and manage costs. Its focused model has driven strong demand and set it apart in a niche that's expanding quickly within the healthcare sector.
Read More
Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue?
Published: November 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
PGNY vs. HQY: Which Stock Is the Better Value Option?
Published: November 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical Services sector have probably already heard of Progyny (PGNY) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors?
Read More
Progyny, Inc. to Present at Jefferies Global Healthcare Conference
Published: November 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that Mark Livingston, Progyny's Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 3:00 p.m. GMT / 10:00 a.m. ET.
Read More
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
Published: October 23, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period ended September 30, 2025 after the close of the market on Thursday, November 6, 2025.
Read More
Are Investors Undervaluing Progyny (PGNY) Right Now?
Published: October 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause
Published: October 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc . (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced the launch of its pregnancy, postpartum, and menopause programs for global employers, available starting January 1, 2026.
Read More
Is Progyny (PGNY) Stock Undervalued Right Now?
Published: October 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Progyny CEO Named World Economic Forum Champion for Women's Health
Published: October 07, 2025 by: GlobeNewsWire
Sentiment: Neutral
Progyny joins global leaders to accelerate advancement in research, innovation, and resilience in women's health Progyny joins global leaders to accelerate advancement in research, innovation, and resilience in women's health
Read More
Surging Earnings Estimates Signal Upside for Progyny (PGNY) Stock
Published: September 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Read More
Progyny (PGNY) Earnings Expected to Grow: Should You Buy?
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
New Progyny Study Reveals Gap Between Perceptions and Realities in Women's Health Benefits Coverage
Published: July 30, 2025 by: GlobeNewsWire
Sentiment: Neutral
Increased awareness of expanded women's health and family building solutions has led to a growing disconnect between most wanted employee benefits and employer offerings Increased awareness of expanded women's health and family building solutions has led to a growing disconnect between most wanted employee benefits and employer offerings
Read More
Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report?
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause
Published: July 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced a new partnership with ŌURA , maker of the world's leading smart ring, further empowering women to better understand and take action on their health through comprehensive data and personalized insights.
Read More
Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women's Health
Published: June 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
With nearly one third of women impacted by pelvic floor disorders, expanded care access and education from Progyny will help eliminate the silent suffering With nearly one third of women impacted by pelvic floor disorders, expanded care access and education from Progyny will help eliminate the silent suffering
Read More
Progyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building Solution
Published: June 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building, and menopause benefits. The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building, and menopause benefits.
Read More
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors
Published: May 29, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced the addition of healthcare veteran Elizabeth Bierbower to its Board of Directors.
Read More
Progyny Appoints Two Renowned Women's Health Experts to Medical Advisory Board
Published: May 14, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced the appointment of Morehouse School of Medicine's Regional Dean for Seattle and Puget Sound's Dr. Gloria Richard-Davis – a double-board certified physician in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, a fellow of the American College of Obstetricians & Gynecologists (FACOG), and a Menopause Society Certified Practitioner (MSCP) – and Columbia University's Dr. Whitney Booker – a double-board certified physician in Obstetrics and Gynecology and Maternal-Fetal Medicine – to its Medical Advisory Board. “As Progyny …
Read More
GDRX vs. PGNY: Which Stock Should Value Investors Buy Now?
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Medical Services sector might want to consider either GoodRx Holdings, Inc. (GDRX) or Progyny (PGNY). But which of these two stocks is more attractive to value investors?
Read More
Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report
Published: April 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building, will report its financial results for the quarterly period ended March 31, 2025, after the close of the market on Thursday, May 8, 2025.
Read More
Why Progyny (PGNY) is Poised to Beat Earnings Estimates Again
Published: April 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer
Published: April 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
The leadership additions support the company's continued ability to scale as it delivers the right care model for women's health and family building The leadership additions support the company's continued ability to scale as it delivers the right care model for women's health and family building
Read More
Progyny Expands Maternal Health Support with Addition of Doula Services
Published: March 31, 2025 by: GlobeNewsWire
Sentiment: Neutral
Available to employers and health plans, the in-person and virtual doula care services can close more care gaps and improve health outcomes Available to employers and health plans, the in-person and virtual doula care services can close more care gaps and improve health outcomes
Read More
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering
Published: March 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation
Read More
Progyny, Inc. to Participate in Upcoming Investor Conferences
Published: March 07, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced it expects to participate in several upcoming investor conferences. Progyny executives will participate in a fireside chat at the Leerink Partners Global Healthcare Conference in Miami, FL on Monday, March 10, 2025, at 11:20 a.m. Eastern Time. The executives will then be participating in meetings at the Barclays 27th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 11, 2025.
Read More
Progyny, Inc. (PGNY) Q4 2024 Earnings Call Transcript
Published: February 27, 2025 by: Seeking Alpha
Sentiment: Neutral
Progyny, Inc. (NASDAQ:PGNY ) Q4 2024 Earnings Conference Call February 27, 2025 4:45 PM ET Company Participants James Hart - Investor Relations Pete Anevski - Chief Executive Officer Mark Livingston - Chief Financial Officer Michael Sturmer - President Conference Call Participants Anne Samuel - JPMorgan Michael Cherny - Leerink Partners John Pinney - Canaccord Genuity Scott Schoenhaus - KeyBanc Jailendra Singh - Truist Securities Allen Lutz - Bank of America Sarah James - Cantor Constantine Davides - Citizens JMP Jenny Shen - BTIG Operator Good day, ladies and gentlemen. Welcome to the Progyny, Inc. Fourth Quarter Earnings Conference Call.
Read More
Progyny, Inc. Announces Fourth Quarter 2024 Results
Published: February 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
Reports Quarterly Revenue of $298.4 Million, Reflecting 10.6% GrowthGenerated $52.2 Million of Quarterly Operating Cash FlowIssues Financial Guidance for 2025, Reflecting Tenth Consecutive Year of Revenue Growth
Read More
About Progyny, Inc. (PGNY)
- IPO Date 2019-10-25
- Website https://www.progyny.com
- Industry Medical - Healthcare Information Services
- CEO Peter Anevski
- Employees 675